Welcome to The GeoWire , your Source for a Peek into GeoInvesting’s Research Coverage, Microcap Stock Education, Case Studies, Recommended Reading From Around the Web, Important Tweets of the Week, Premium Weekly Wrap Ups, Featured Videos, and More. Please hit the heart button if you like today’s newsletter and reply with any feedback.
If you are new or this was shared with you, you can join our email list here. Or you can click here to get all of our premium content.
We had a second opportunity to sit down with Cipher Pharmaceuticals Inc (OOTC:CPHRF) (CPH.TO) CEO Craig Mull and CFO Bryan Jacobs on May 18, 2023.
Recall that after having taken a deeper look in 2022 into the the valuation of the company versus its peers and some of the traits it possessed that made the company a stock that we thought warranted a live event with management, we successfully hosted a Fireside Chat with the company in November 2022.
In May 18’s Management Morning Briefing, we aimed to gain a deeper understanding of Cipher Pharmaceuticals’ prospects and how they align with our findings and past discussions.
Continue viewing below for notable clips relating to the company’s acquisition strategy, product development, and a small highlight of the discussion on Q1 2023 results.
part of this post is for paying subscribers
Already a paying member? Log in and come back to this page.
Our premium members also…
Get Access all Model Portfolios
Receive GeoInvesting Premium Alerts
Access to all stock pitches and Research Reports
Attend live interviews and fireside chats
Interact with the GeoTeam in Monthly Forums
Get in-depth stock research on 1000’s of microcap stocks